Suicide prevention telehealth platform Vita Health has raised $22.5 million in Series A funding. LFE Capital, CVS Health Ventures, Athyrium Capital Management, Flare Capital Partners, Connecticut Innovations, CU Healthcare Innovation Fund and HopeLab participated in the round. How will the new investment be used?
Also See: Claris Bio Receives Investment
What do we know about Vita Health? It connects telehealth providers with young people and adults who are considering suicide. The platform also provides teletherapy and psychiatry services for people with behavioural health conditions. Suicide is one of the leading causes of death in the US and the suicide rate increased by 2.6 per cent from 2021 to 2022. Vita Health also generated $8.38 million in 2022. Other digital health companies working to address suicidal thoughts include mental health benefits provider Lyra Health and publicly traded digital behavioural health company Talkspace.
Our common motivation was to change a very deadly curve with far-reaching and lasting consequences for everyone in our society. We were honoured to be joined by a large group of diverse, experienced and strategic investors. We are expanding our reach to directly address the most challenging mental health issues with a growing roster of health plan partners, provider partners, employers, colleges and universities.
Lynn Hamilton, co-founder and CEO of Vita Health